AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update
15 nov. 2024 07h29 HE
|
AIM ImmunoTech Inc.
– Continued execution across Ampligen® clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer space – Driving significant momentum with...
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
14 nov. 2024 16h10 HE
|
Fortress Biotech, Inc.
Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or locally...
60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results
14 nov. 2024 14h31 HE
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharma (SXTP) reported 164% revenue growth and clinical progress on ARAKODA® for infectious diseases and babesiosis in its 3Q24 earnings report.
PharmAla Reaches Agreement in Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License
14 nov. 2024 09h20 HE
|
PharmAla Biotech
PharmAla reaches agreement in principle to trade with a clinical trial to trade its LaNeo MDMA for a data license to the trial outcomes.
French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance
11 nov. 2024 12h43 HE
|
AdipoPharma
STRASBOURG, France, Nov. 11, 2024 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the US and Belgium developing a novel and promising Type 2 diabetes drug,...
PharmAla to supply LaNeo MDMA for Clinical Trial at Yale
07 nov. 2024 09h20 HE
|
PharmAla Biotech
PharmAla to supply Yale University with MDMA for clinical trial
Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review 2024: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
06 nov. 2024 08h56 HE
|
Research and Markets
Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The "Zollinger-Ellison Syndrome (Gastrinoma) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. ...
Quoin Pharmaceuticals Initiates Clinical Testing of Lead Product in Pediatric Netherton Syndrome Patient
05 nov. 2024 08h00 HE
|
Quoin Pharmaceuticals, Inc.
Clinical Assessment Is Being Performed on a Pediatric Patient at Children’s Health Ireland in Dublin First Evaluation of QRX003 in a Pediatric Patient Second Clinical Site to Open in Spain with...
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
31 oct. 2024 09h00 HE
|
NAYA Biosciences, Inc.
SARASOTA, Fla. and MIAMI, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NAYA Biosciences (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in...
H1 Expands Trial Landscape with U.K. Diversity Data to Enhance Clinical Trial Equity and Meet Evolving Regulatory Standards
30 oct. 2024 09h00 HE
|
H1
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- H1, on a mission to connect the world to the right doctors, today announced that diversity data and insights on 34 million patients being treated within...